Verséa Health, Inc. Launches Verséa Easy Lab™, Affordable, Highly Accurate Over-the-Counter (OTC) Product Line
15 Aug 2023
Diagnostic Reagents
TAMPA, Fla.--(BUSINESS WIRE)-- Verséa Health, Inc. (“Verséa”), a Florida-based health care company engaged in the commercialization of innovative diagnostics and therapeutics, has launched the Verséa Easy Lab™ product line of rapid, at-home, over-the-counter diagnostic tests that will be sold at retail locations nationwide. The affordable, FDA approved, and professional quality tests will enable people to check up on their health at any time and in the comfort of their homes. Verséa Easy Lab™ brings together for the first time a broad range of home use diagnostic test segments under one consumer driven national brand, and aims to put better, more rapid information on people’s health in their hands.
Currently available tests provide nearly instant results and interpretation for: pregnancy, ovulation, iFOBT (colon health screening), and 6-panel drugs of abuse testing.
James Olin, Chief Commercial Officer at Verséa Health, Inc. explained the reason behind the launch: “The Verséa Easy Lab™ product line was created with a mission to give millions of Americans direct access to the most essential and necessary health care services with an emphasis on prediction, prevention, and value. Currently this access is out of reach for many Americans because high-deductible health plans now dominate the marketplace. Our goal is to provide economically accessible care through the disruption of traditional care channels and “de-medicalize” basic healthcare for most Americans. By providing instant, direct access to the most desired and necessary healthcare services individuals can take control of their health, health information and level of care and intervention. This launch also strategically fits with our focus on supporting new and more accessible locations of care like urgent care clinics and independent community pharmacies.”
To learn more about Verséa Health, Inc. and the Verséa Easy Lab™ product line, visit the Verséa Health webpage or contact directly at info@versea.com or 1-800-397-0670
About Verséa Health, Inc.
Verséa Health, Inc. (“Verséa”) headquartered in Tampa, FL, is a U.S. healthcare company founded by experienced business executives and prominent scientific medical experts, all committed to transforming scientific discoveries into applicable healthcare & wellness solutions that are critical to improving patients’ lives. To learn more, visit:
View source version on businesswire.com:
Contacts
Verséa Health, Inc.
James M. Olin, CCO
1-800-397-0670
jolin@versea.com
Source: Verséa Health, Inc.
View this news release online at:
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.